Results 271 to 280 of about 37,162 (308)
Some of the next articles are maybe not open access.

Second-Generation Antipsychotics

2010
Michael M. Morgan   +199 more
openaire   +1 more source

[Diabetes and second-generation (atypical) antipsychotics].

Annales d'endocrinologie, 2010
Schizophrenia is a common psychiatric illness (1% of the general population), characterized by the association of positive and negative symptoms and cognitive disorders. Antipsychotics, typical or atypical, are known to induce in patients with schizophrenia weight gain and abnormalities in glucose and lipid metabolisms. These modifications, in addition
Chabroux, S., Haffen, E., Penfornis, A.
openaire   +2 more sources

Cognitive Effects of Second-Generation Antipsychotics

2009
Historically, pharmacotherapy for schizophrenia was mainly focused on finding drugs to treat psychotic symptoms only, without addressing other crucial domains of the disorder such as cognitive impairments. As a result, these domains have remained undertreated.
F. Fumagalli   +3 more
openaire   +1 more source

Second-generation antipsychotics and the metabolic syndrome

Current Psychiatry Reports, 2005
Prakash S, Masand, Rajnish, Mago
openaire   +2 more sources

Tardive Dyskinesia and Second-Generation Antipsychotics

American Journal of Psychiatry, 2005
SUDEEP SARAF, PRABHA S. CHANDRA
openaire   +2 more sources

Assessing the Costs of Second-Generation Antipsychotics

Psychiatric Services, 2012
Paul N, Pfeiffer, Marcia, Valenstein
openaire   +2 more sources

Home - About - Disclaimer - Privacy